Literature DB >> 6219830

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

H B Hubert, M Feinleib, P M McNamara, W P Castelli.   

Abstract

The relationship between the degree of obesity and the incidence of cardiovascular disease (CVD) was reexamined in the 5209 men and women of the original Framingham cohort. Recent observations of disease occurrence over 26 years indicate that obesity, measured by Metropolitan Relative Weight, was a significant independent predictor of CVD, particularly among women. Multiple logistic regression analyses showed that Metropolitan Relative Weight, or percentage of desirable weight, on initial examination predicted 26-year incidence of coronary disease (both angina and coronary disease other than angina), coronary death and congestive heart failure in men independent of age, cholesterol, systolic blood pressure, cigarettes, left ventricular hypertrophy and glucose intolerance. Relative weight in women was also positively and independently associated with coronary disease, stroke, congestive failure, and coronary and CVD death. These data further show that weight gain after the young adult years conveyed an increased risk of CVD in both sexes that could not be attributed either to the initial weight or the levels of the risk factors that may have resulted from weight gain. Intervention in obesity, in addition to the well established risk factors, appears to be an advisable goal in the primary prevention of CVD.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219830     DOI: 10.1161/01.cir.67.5.968

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  782 in total

1.  Treatment for morbid obesity.

Authors:  A R Carmichael
Journal:  Postgrad Med J       Date:  1999-01       Impact factor: 2.401

2.  Relationship between lifestyle and serum lipid and lipoprotein levels in middle-aged Japanese men.

Authors:  N Nakanishi; K Nakamura; S Ichikawa; K Suzuki; K Tatara
Journal:  Eur J Epidemiol       Date:  1999-04       Impact factor: 8.082

Review 3.  The medical risks of obesity.

Authors:  F Xavier Pi-Sunyer
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

Review 4.  Impact of dyslipidaemia. Lessons from clinical trials.

Authors:  W V Brown
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

Review 5.  Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review.

Authors:  R Padwal; S E Straus; F A McAlister
Journal:  BMJ       Date:  2001-04-21

Review 6.  Cardiovascular consequences of obese and nonobese obstructive sleep apnea.

Authors:  Kannan Ramar; Sean M Caples
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

7.  Effectiveness of A Four-Week Diet Regimen, Exercise and Psychological Intervention for Weight Loss.

Authors:  Tobias Weinreich; Hans-Peter Filz; Ursula Gresser; Barbara M Richartz
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Traditional and nontraditional cardiovascular risk factors in comorbid insomnia and sleep apnea.

Authors:  Faith S Luyster; Kevin E Kip; Daniel J Buysse; Aryan N Aiyer; Steven E Reis; Patrick J Strollo
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

9.  The systolic blood pressure difference between arms and cardiovascular disease in the Framingham Heart Study.

Authors:  Ido Weinberg; Philimon Gona; Christopher J O'Donnell; Michael R Jaff; Joanne M Murabito
Journal:  Am J Med       Date:  2013-11-25       Impact factor: 4.965

10.  Implantable loop recorders in patients with unexplained syncope: Clinical predictors of pacemaker implantation.

Authors:  Martin Huemer; Ann-Kristin Becker; Alexander Wutzler; Philipp Attanasio; Abdul S Parwani; Philipp Lacour; Leif-Hendrik Boldt; Burkert Pieske; Wilhelm Haverkamp; Florian Blaschke
Journal:  Cardiol J       Date:  2018-02-05       Impact factor: 2.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.